Live Chat ×
Skip to main content

Diagnostic Hematopathology: An Update

From the 2019 Joint Annual Meeting (June 26, 2019)
Presented by Kamran Mirza, M.D., Ph.D., FCAP, FASCP, MLS(ASCP)
With rapid advances in molecular techniques, the world of diagnostic hematopathology has undergone rapid updates. Many of these have been fortified in the latest World Health Organization (WHO) classification. This presentation provides an update on key changes in the new WHO from the perspective of the medical laboratory scientist and provides historic insight into how these updates have evolved.

LEARNING OBJECTIVES
At the conclusion of this presentation, participants will be able to

  1. Recall the evolution of diagnostic hematopathology
  2. Illustrate the role of clinical and molecular data in the updated version of the WHO Classification of tumors of hematopoietic and lymphoid tissues
  3. Describe the role of Medical Laboratory Science in current day hematopathology diagnosis
CE ACCREDITATION
This recorded presentation is P.A.C.E. ® accredited. The instruction level for this activity is Intermediate. One (1) P.A.C.E. ® contact hour and one (1) Florida credit hour in the area General (Molecular Pathology) will be awarded to participants. ASCLS P.A.C.E.® is accepted by the ASCP/ASCLS/AGT Board of Certification and all states, including Florida and California, as an approved provider of continuing education for recertification and licensure. ASCLS is an approved provider with CE Broker for Florida licensees.

LEVEL OF INSTRUCTION
This intermediate-level program is appropriate for laboratory professionals working in clinical, public health and academic settings.